Importantly, inhibition of miR-146a not only modifies the STAT3-associated cytokine profile but also attenuates HCC-induced NK dysfunction and enhances the antitumor activity of lymphocytes. This evidence concerns the gene STAT3 and hepatocellular carcinoma.